Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Friday Links

Posted on June 9, 2023June 9, 2023 by John C. Goodman
  • Could redistribution of income make people healthier? Evidence that the answer is “yes.”
  • 330 COVID-19 articles in science journals have been retracted.
  • NYC to help patients compare hospital costs. (NYT)
  • More from Graboyes on sterilization.
  • Steve Moore to Congress: ESG is harmful to retirees.
  • Merck sues over IRA drug price negotiation: It’s an unconstitutional “taking” and it also “compels speech.”
+

Thursday Links

Posted on June 8, 2023June 7, 2023 by John C. Goodman
  • AEI: Return the savings from site neutral payments to the hospitals. It’s called taking from the rich and then giving back to the rich.
  • Where are we on the status of (legally) importing drugs from Canada? We’re getting close.
  • Update on hospital price transparency: “The widescale noncompliance of 75.5% of hospitals is due to most hospitals’ files being incomplete, illegible, or not having prices clearly associated with both payer and plan.”
  • A new model for cell and gene therapies: Medicaid pays only if they work.
  • AI Quote of the week:

So far I have explained why four of the five most often proposed risks of AI are not actually real – AI will not come to life and kill us, AI will not ruin our society, AI will not cause mass unemployment, and AI will not cause an ruinous increase in inequality. But now let’s address the fifth, the one I actually agree with: AI will make it easier for bad people to do bad things.

Marc Andreessen via Tyler Cowen

+

Why Don’t Some Promising Drugs Come to Market?

Posted on June 6, 2023June 5, 2023 by Devon Herrick

Earlier this year I wrote about bacteriophages, naturally-occurring antibiotics that are not widely available. Phases, as they’re called, are viruses found in nature that kill bacteria. Each is highly specific, killing only one kind of bacteria. That is (possibly) why pharmaceutical companies haven’t shown a lot of interest in developing them as antibiotic drug therapies. Drug companies would need to develop a different bacteriophage therapy for each pathogen targeted. Although mostly ignored by Western drug companies, phages were common in former Soviet-bloc countries. The following is an article about a rare, drug-resistant bacteria that affected Gulf War soldiers treatable only by phages.

+

Monday Links

Posted on June 5, 2023June 5, 2023 by John C. Goodman
  • Why the new food stamp work requirements matter.
  • Republicans have been as bad as Democrat’s when it comes to federal regulations.
  • How much do you like your job? 9 of 10 workers would give up a quarter of their lifetime earnings to do meaningful work. (WSJ)
  • Johns Hopkins study: less than 10% of Texas hospitals ever sued a patient for an unpaid bill. Even in those cases, the hospitals’ recovery was scanty and half the time the patients didn’t even show up at the hearing.
  • But here is an exception: A rich nonprofit hospital denies care to patients who don’t pay their bills. (NYT)
  • Noah Smith: there is a need for libertarianism after all. HT: Tyler
+
  • Previous
  • 1
  • …
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • …
  • 263
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 49 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom